Ph-TRAP Crystalline Alcoholate for Stable Ligand Isolation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional synthesis methods for Ph-TRAP, a diphosphine compound used as a ligand for asymmetric hydrogenation of aromatics, require impractical reagents and solvents, result in unstable products, and are difficult to purify, making industrial production challenging.
Innovation Solution
A novel method to produce Ph-TRAP·(BH3)2, a diphosphine-diborane complex, from commercially available N,N-dimethyl-1-ferrocenylethylamine, followed by conversion to a crystalline alcohol solvate Ph-TRAP·n-BuOH, which is stable and easy to isolate and purify.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional synthesis methods are used to produce Ph-TRAP, then the ligand can be obtained for asymmetric hydrogenation, but the product is unstable and difficult to purify
Solution Approach 1:
The patent changes the physical and chemical parameters of the final product by converting unstable Ph-TRAP into a stable crystalline solvate form through controlled solvation with n-butyl alcohol. This parameter change from unstable liquid/amorphous form to stable crystalline solvate resolves the contradiction between product stability and purification ease
Solution Approach 2:
The patent creates a composite material system where Ph-TRAP forms a solvate complex with n-butyl alcohol molecules in a defined stoichiometric ratio (Ph-TRAP·n-BuOH). This composite crystalline structure combines the catalytic activity of Ph-TRAP with the stabilizing and structuring effect of the alcohol solvent, resolving both stability and purification issues
2Ease of manufacture
If conventional synthesis methods are used for Ph-TRAP, then the ligand can be produced, but impractical reagents and solvents are required
Solution Approach 1:
The patent replaces expensive, unstable, and impractical reagents (such as lithium diphenylphosphinite and various heavy metals) with commercially available, stable, and easy-to-handle alternatives. The new method uses readily available starting materials that can be stored and handled under normal conditions, making the synthesis practical for industrial application
Solution Approach 2:
The patent introduces a borane intermediate (Ph-TRAP·(BH3)2) as a stable precursor that facilitates the synthesis. This intermediary compound serves as a bridge between the starting materials and the final product, enabling a more practical synthesis route that avoids the use of impractical reagents while maintaining the ability to produce the desired ligand
3Productivity
If conventional synthesis methods are used for Ph-TRAP, then the ligand can be obtained, but the production process is complex and inefficient
Solution Approach 1:
The patent divides the synthesis process into distinct modular stages: (1) formation of the borane complex intermediate, (2) reaction with magnesium to form Grignard reagent, (3) formation of Ph-TRAP·(BH3)2, and (4) conversion to the final alcohol solvate. This segmentation allows each step to be optimized independently and simplifies the overall process control, resolving the contradiction between productivity and process complexity
Solution Approach 2:
The patent utilizes phase transitions, particularly the crystallization of Ph-TRAP·(BH3)2 and the final alcohol solvate from solution. These phase transitions provide natural separation and purification steps that simplify the process and improve productivity by eliminating the need for complex purification procedures
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The crystalline alcohol solvate exhibits remarkable crystallinity, air stability, and ease of isolation, facilitating practical application and improving the efficiency of asymmetric hydrogenation reactions.
Implementation Method 1
crystalline alcohol solvate of 2,2''-bis[1-(diphenylphosphino)ethyl]-1,1''-biferrocene
Data Source
Figure 1
Figure 2~3
Figure 4
AI summary
The present invention relates to a product form having excellent crystallinity and air stability of 2,2"-bis[1-(diphenylphosphino)ethyl]-1,1"-biferrocene (Ph-TRAP) which is useful as an aromatic asymmetric hydrogenation ligand but is difficult to be synthesized or isolated and purified, and a method for efficiently producing the product form. The present invention provides: a crystalline alcoholate composed of Ph-TRAP and an alcohol; and a method for producing the crystalline alcoholate, the method comprising reacting Ph-TRAP(BH3)2 represented by general formula (1·(BH3)2) with an alcohol.